Literature DB >> 5100389

Drug dosage and remission duration in childhood lymphocytic leukemia.

D Pinkel, K Hernandez, L Borella, C Holton, R Aur, G Samoy, C Pratt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5100389     DOI： 10.1002/1097-0142(197102)27:2<247::aid-cncr2820270202>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  45 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.

Authors:  W E Evans; M V Relling
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

3.  Immunosuppression and immunostimulation in acute leukaemia.

Authors:  C M MacLennan
Journal:  Proc R Soc Med       Date:  1975-04

4.  Importance of 6-mercaptopurine dose in lymphoblastic leukaemia.

Authors:  J P Hale; J S Lilleyman
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

5.  Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).

Authors:  R Scherrer; K Geissler; P A Kyrle; H Gisslinger; U Jäger; P Bettelheim; K Laczika; G Locker; C Scholten; C Sillaber
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

6.  Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.

Authors: 
Journal:  Br Med J       Date:  1971-10-23

7.  Prolonged remission in Di Guglielmo's syndrome.

Authors:  R Carr; E M Innes
Journal:  Postgrad Med J       Date:  1983-01       Impact factor: 2.401

8.  Competitive protein binding assay for methotrexate.

Authors:  C E Myers; M E Lippman; H M Elliot; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 9.  High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors.

Authors:  C F LeMaistre; W A Knight
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

10.  Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.

Authors:  P J Kearney; P A Light; A Preece; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.